World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
77466
World Ranking
8095
National Ranking
307

Clive Kearon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Clive Kearon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 322 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Clive Kearon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Clive Kearon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Clive Kearon was affiliated with McMaster University in Canada and contributed extensively to the field of Medicine, with a particular focus on Internal Medicine, Cardiology and Cardiovascular Medicine, Surgery, Hematology, and Epidemiology.

The scientist's research primarily centered on topics involving the diagnosis and management of venous thromboembolism, atrial fibrillation management and outcomes, mechanisms of blood coagulation and thrombosis, issues related to central venous catheters and hemodialysis, diagnosis and treatment of venous diseases, cardiac anesthesia and surgical outcomes, and acute ischemic stroke management.

Clive Kearon authored several notable papers including:

  • "Antithrombotic Therapy for VTE Disease," 2021, published in CHEST Journal
  • "Executive Summary," 2021, published in CHEST Journal
  • "Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial," 2020, published in The Lancet
  • "Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism," 2021, published in Annals of Internal Medicine
  • "Long-term treatment of venous thromboembolism," 2020, published in Blood

Frequent co-authors who collaborated with Clive Kearon included:

  • Susan R. Kahn
  • Sameer Parpia
  • Marc Rodger
  • Grégoire Le Gal
  • Sam Schulman

Publications appeared predominantly in the following venues:

  • Journal of Thrombosis and Haemostasis
  • Blood
  • Thrombosis and Haemostasis
  • Journal of Vascular Surgery Venous and Lymphatic Disorders
  • CHEST Journal

Best Publications

  • Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

    Clive Kearon;Elie A. Akl;Anthony J. Comerota;Paolo Prandoni

  • Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report

    Clive Kearon;Elie A. Akl;Elie A. Akl;Joseph Ornelas;Allen Blaivas

  • Dabigatran versus warfarin in the treatment of acute venous thromboembolism

    Sam Schulman;Clive Kearon;Ajay K. Kakkar;Patrick Mismetti

  • Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    Clive Kearon;Susan R. Kahn;Giancarlo Agnelli;Samuel Goldhaber

  • Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer

    Philip S. Wells;David R. Anderson;Marc Rodger;Jeffrey S. Ginsberg

  • Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis

    Philip S. Wells;David R. Anderson;Marc Rodger;Melissa Forgie

  • Natural History of Venous Thromboembolism

    Clive Kearon

  • A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

    Clive Kearon;Michael Gent;Michael Gent;Jack Hirsh;Jack Hirsh;Jeffrey Weitz

  • Use of a clinical model for safe management of patients with suspected pulmonary embolism.

    Philip S. Wells;Jeffrey S. Ginsberg;David R. Anderson;Clive Kearon

  • Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

    Sam Schulman;Clive Kearon;Ajay K. Kakkar;Sebastian Schellong

  • Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

    Sam Schulman;Ajay K. Kakkar;Samuel Z. Goldhaber;Sebastian Schellong

  • Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

    Clive Kearon;Jeffrey S. Ginsberg;Michael J. Kovacs;David R. Anderson

  • A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome

    Mark A. Crowther;Jeff S. Ginsberg;Jim Julian;Judah Denburg

  • Hemorrhagic Complications of Anticoagulant Treatment

    Mark N. Levine;Gary Raskob;Seth Landefeld;Clive Kearon

  • Accuracy of clinical assessment of deep-vein thrombosis

    PhilipS. Wells;Jack Hirsh;DavidR. Anderson;AnthonyW.A. Lensing

  • Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

    JW tenCate;HR Buller;M Gent;J Hirsh

  • Management of anticoagulation before and after elective surgery.

    Clive Kearon;Jack Hirsh

  • Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

    Sam Schulman;Rebecca J. Beyth;Clive Kearon;Mark N. Levine

  • Noninvasive Diagnosis of Deep Venous Thrombosis

    C Kearon;J A Julian;T E Newman;J S Ginsberg

  • Aspirin in Patients Undergoing Noncardiac Surgery

    M. Mrkobrada;M. Mrkobrada;K. Leslie;P. Alonso-Coello;A. Kurz

Frequent Co-Authors

Jeffrey S. Ginsberg
Jeffrey S. Ginsberg McMaster University
Jim A. Julian
Jim A. Julian McMaster University
Sam Schulman
Sam Schulman McMaster University
Susan R. Kahn
Susan R. Kahn McGill University
James D. Douketis
James D. Douketis McMaster University
Jack Hirsh
Jack Hirsh McMaster University
Mark Crowther
Mark Crowther McMaster University
Marc A. Rodger
Marc A. Rodger Ottawa Hospital
Philip S. Wells
Philip S. Wells Ottawa Hospital
Samuel Z. Goldhaber
Samuel Z. Goldhaber Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a future in Medicine but want diverse or flexible options, there are several related online degree programs and career pathways to explore. For example, aspiring pharmacists can look into pharmacy school online, which offers coursework that can be completed remotely before clinical experience.

Those interested in the intersection of healthcare and technology might pursue an online bachelor's in health information management. This degree prepares graduates for roles in maintaining and analyzing health data—a field with strong job growth.

For students looking for career-focused programs, getting a medical billing and coding certification cost is often lower than many traditional degrees, enabling quick entry into administrative healthcare roles.

Nurses who wish to advance may opt for the cheapest online nurse practitioner programs. These affordable online options help professionals balance work and study while progressing their careers.

Best Scientists Citing Clive Kearon

Recently Published Articles